Note 20 - Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Net revenue	$ 81,002	$ 107,399
Income (loss) from operations	(5,254)	(17,065)
Depreciation and amortization	7,456	7,387
Stock-based compensation expense	2,913	6,046
Restructuring costs	2,365	0
Impairment and write-off expense		5,705
Rx Segment [Member]
Net revenue	65,183	73,799
Income (loss) from operations	(1,590)	(7,358)
Depreciation and amortization	5,909	6,271
Stock-based compensation expense	2,373	5,722
Restructuring costs	2,156
Impairment and write-off expense		2,730
Consumer Health [Member]
Net revenue	15,819	33,600
Income (loss) from operations	(3,664)	(9,707)
Depreciation and amortization	1,547	1,116
Stock-based compensation expense	540	324
Restructuring costs	$ 209
Impairment and write-off expense		$ 2,975